HIV-1 Encephalopathy and AIDS Dementia Complex: Multimedia

References

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients with HIV/AIDS. In: Practice Guidelines for the Treatment of Psychiatric Disorders. 2004:137-248.

2. Antinori A, Giancola ML, Grisetti S, et al. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS. Sep 27 2002;16(14):1867-76. [Medline].

3. Bradley WG, Daroff RB, Fenichel GM. Neurologic manifestations of human immunodeficiency virus infection in children. In: Neurology in Clinical Practice. 2. 2004:1603-1611.

4. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. Feb 1999;52(3):607-13. [Medline].

5. Chiriboga CA, Fleishman S, Champion S, et al. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr. Mar 2005;146(3):402-7. [Medline].

6. Dore GJ, McDonald A, Li Y, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. Jul 4 2003;17(10):1539-45. [Medline].

7. Ernst T, Chang L, Jovicich J, et al. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology. Nov 12 2002;59(9):1343-9. [Medline].

8. Gendelman HE, Lipton SA, Epstein L. The Neurology of AIDS. New York: Chapman & Hall;1998.

9. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol. Jan 2005;5(1):69-81. [Medline].

10. Manji H, Miller R. The neurology of HIV infection. J Neurol Neurosurg Psychiatry. Mar 2004;75 Suppl 1:i29-35. [Medline].

11. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. Nov 1993;43(11):2245-52. [Medline].

12. McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. Dec 2004;157(1-2):3-10. [Medline].

13. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. Dec 1 2002;186 Suppl 2:S193-8. [Medline].

14. Nath A, Anderson C, Jones M, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000;14(3):222-7. [Medline].

15. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:517-524. [Medline].

16. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986;19:525-535. [Medline].

17. Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol. May 2006;61(5):393-401. [Medline].

18. Pajeau AK, Roman GC. HIV encephalopathy and dementia. Psychiatr Clin North Am. Jun 1992;15(2):455-66. [Medline].

19. Price RW, Perry SW. HIV, AIDS, and the Brain. New York: Raven Press;1994. [Medline].

20. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis. Nov 1988;158(5):1079-83. [Medline].

21. SMART study group, El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. Nov 30 2006;355(22):2283-96. [Medline].

22. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. Jan 23 2001;56(2):257-60. [Medline].

23. Sacktor N, Nakasujja N, Skolasky R. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. Jul 25 2006;67(2):311-4. [Medline].

24. Said G, Saimont AG, Lacroix C. Neurological Complications of HIV and AIDS. Philadelphia: WB Saunders; 1998.

25. Schutzer SE, Brunner M, Fillit HM, Berger JR. Autoimmune markers in HIV-associated dementia. J Neuroimmunol. May 2003;138(1-2):156-61. [Medline].

26. Sevigny JJ, Albert SM, McDermott MP. An evaluation of neurocognitive status and markers of immune activation aspredictors of time to death in advanced HIV infection. Arch Neurol. 2007;64(1):97-102. [Medline].

27. Thomas FP, Chalk C, Lalonde R, et al. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol. Nov 1994;68(11):7099-107. [Medline].

28. Wong MH, Robertson K, Nakasujja N. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. Jan 30 2007;68(5):350-5. [Medline].

29. de Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg. 1989;91(3):199-219. [Medline].

Further Reading

Keywords

AIDS dementia complex, ADC, HIV-1–associated cognitive/motor complex, AIDS encephalopathy, HIV encephalopathy, subacute HIV encephalitis, HIV-associated dementia complex, AIDS-related dementia, HIV dementia, acquired immunodeficiency syndrome, AIDS, human immunodeficiency virus, HIV, minor cognitive motor disorder, MCMD, highly active antiretroviral therapy, HAART

Contributor Information and Disclosures

Author

Niranjan N Singh, MD, DNB, Fellow in Neurophysiology, Department of Neurology, St Louis University School of Medicine
Niranjan N Singh, MD, DNB is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Coauthor(s)

Sofia Yahya, MD, Staff Physician, Department of Psychiatry, Barnes-Jewish Hospital, Washington University School of Medicine
Sofia Yahya, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: Nothing to disclose.

Mandeep Garewal, MD, Staff Physician, Department of Neurology, Saint Louis University School of Medicine
Mandeep Garewal, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, and American Society of Neuroimaging
Disclosure: Nothing to disclose.

Florian P Thomas, MD, MA, PhD, DrMed, Associate Chief of Staff, St Louis VA Medical Center; Associate Director, Neurology Residency Program; Professor, Departments of Neurology, Molecular Virology, and Molecular Microbiology and Immunology, Saint Louis University School of Medicine
Florian P Thomas, MD, MA, PhD, DrMed is a member of the following medical societies: American Academy of Neurology and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

Medical Editor

Michael J Schneck, MD, Associate Professor, Department of Neurology and Neurosurgery, Loyola University Chicago, Stritch School of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale
Richard J Caselli, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, American Neurological Association, and Sigma Xi
Disclosure: Nothing to disclose.

CME Editor

Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital
Matthew J Baker, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.